Patents by Inventor Yin Lei

Yin Lei has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MDM2 inhibitors
    Patent number: 11339171
    Abstract: A compound capable of being used as a tumor inhibitor, a preparation method therefor, and application thereof. The compound has a structure represented by general formula I; a stereoisomer, an enantiomer, a raceme, a cis/trans isomer, a tautomer, and an isotopic variant of the compound are comprised; the compound can be used separately or in combination with other drugs for treating tumors or inflammatory diseases, or for treating other disorders or diseases mediated by the activity of MDM2 and/or MDM4, and shows prominent curative activity.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: May 24, 2022
    Assignee: Gan & Lee Pharmaceuticals
    Inventors: Yin Lei, Yao Zhenglin, Li Heng
  • MDM2 Inhibitors
    Publication number: 20210079007
    Abstract: A compound capable of being used as a tumor inhibitor, a preparation method therefor, and application thereof. The compound has a structure represented by general formula I; a stereoisomer, an enantiomer, a raceme, a cis/trans isomer, a tautomer, and an isotopic variant of the compound are comprised; the compound can be used separately or in combination with other drugs for treating tumors or inflammatory diseases, or for treating other disorders or diseases mediated by the activity of MDM2 and/or MDM4, and shows prominent curative activity.
    Type: Application
    Filed: December 21, 2018
    Publication date: March 18, 2021
    Applicant: Gan & Lee Pharmaceuticals
    Inventors: Yin Lei, Yao Zhenglin, Li Heng